id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-P-0219-0004,FDA,FDA-2002-P-0219,FDA/OC to King & Spalding LLP,Other,PDN-Petition Denial,2004-08-03T04:00:00Z,2004,8,,,2008-04-12T01:27:15Z,,0,0,0900006480496e6b
FDA-2002-P-0219-0003,FDA,FDA-2002-P-0219,FDA/DDM to King & Spalding LLP,Other,ACK-Acknowledgement Letter,2003-03-12T05:00:00Z,2003,3,,,2008-04-12T01:27:15Z,,0,0,0900006480496e69
FDA-2002-P-0219-0002,FDA,FDA-2002-P-0219,FDA.CDER to King & Spalding,Other,PDN-Petition Denial,2003-02-14T05:00:00Z,2003,2,,,2008-04-12T01:27:15Z,,0,0,0900006480496e62
FDA-2002-P-0219-0001,FDA,FDA-2002-P-0219,FDA/DDM to King & Spalding,Other,ACK-Acknowledgement Letter,2002-06-25T04:00:00Z,2002,6,,,2008-04-12T01:27:15Z,,0,0,0900006480496e1a